% Expired Patents = 25.0

EPO Patents = 1

Forward Citations = 1

Loading Chart...

9 inventors (with patents filed for the assignee):

Byung Soo Youn (4 out of 6 patents)

Ho Sup Yoon (4 out of 6 patents)

Han Soo Kim (4 out of 41 patents)

4. Ik Hwan Kim (2 out of 3 patents)

5. Moon Kee Maeng (1 out of 1 patent)

6. Min Ju Ham (1 out of 1 patent)

7. Baik Lin Seong (1 out of 10 patents)

8. Hyeong Deok Choi (1 out of 1 patent)

9. Jun Hwan Kim (1 out of 1 patent)

10. Jun Hwan Kim (0 patent)

4 patents: Sort by Forward Citations

1. 11298353 - Anti-inflammatory composition (2022-04-12),

2. 10744114 - Use of eupatilin as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity (2020-08-18),

3. 10744113 - Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity (2020-08-18),

4. 10370364 - Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis (2019-08-06),

Company Overview

Osteoneurogen Inc. is a biotechnology company focused on developing novel therapies for neurological and orthopedic disorders. Our innovative treatments leverage cutting-edge technology to enhance bone and nerve regeneration, improving patient outcomes and quality of life. With a strong commitment to research and development, we are dedicated to advancing the field of regenerative medicine and transforming the lives of individuals suffering from debilitating conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#768 in Seoul

#2,202 in South Korea

Seoul, South Korea

Osteoneurogen Inc.

Forward Citations = 1

9 inventors:

Byung Soo Youn (4 out of 6 patents)

Ho Sup Yoon (4 out of 6 patents)

Han Soo Kim (4 out of 41 patents)

4. Ik Hwan Kim (2 out of 3 patents)

5. Moon Kee Maeng (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Osteoneurogen Inc.. Retrieved from https://idiyas.com/company/osteoneurogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]